PSCI has provided extensive IT services to a major global pharmaceutical company for over 20 years.
Client: Major global pharmaceutical company
Engagement: For more than 20 years
Challenge
Our client sought to reduce operational overhead and improve the effectiveness of the discovery phase in their R&D process. They faced challenges related to continuity of service (CoS), specialized clinical IT staffing, and risks associated with talent turnover. Additionally, co-employment concerns limited flexibility in managing external resources, creating potential gaps in critical functions.
Solution
PSCI proposed and implemented a tailored CoS resourcing model designed to provide therapeutic-area support and targeted clinical IT expertise. By working closely with our client’s internal teams, PSCI developed a staffing framework that:
-
Ensured continuity of service for mission-critical projects
-
Reduced risk associated with staff turnover and loss of institutional knowledge
-
Addressed co-employment considerations while maintaining compliance
-
Supported seamless project execution across multiple therapeutic areas
Impact
The CoS model has delivered measurable benefits over the course of the partnership:
-
Sustained operational efficiency and effectiveness in the discovery phase
-
Minimized risk of service disruption due to staff transitions
-
Enhanced collaboration between PSCI and our client’s teams through integrated resourcing
-
Provided a flexible, scalable solution adaptable to evolving R&D needs
PSCI’s long-term partnership with our client underscores its ability to deliver sustainable, risk-mitigated solutions that support critical clinical and project management functions. The CoS model continues to provide consistent, high-quality service today, reflecting PSCI’s commitment to operational excellence and strategic client support.
